Skip to main content
SpringerLink
Log in

A plea for the analysis of Vitamin-D levels in patients under photoprotection, including patients with xeroderma pigmentosum (XP) and basal cell nevus syndrome (BCNS)

  • Letter to the Editor
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Grant WB (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94(6): 1867-1875.

    Google Scholar 

  2. Hyppnonen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birthcohort study. Lancet 358: 1500-1503.

    Google Scholar 

  3. Chun Y, Kong J et al. (2002) 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238.

    Google Scholar 

  4. Holick MF. (2003) Vitamin D: a millenium perspective. J Cell Biochem 88: 296-307.

    Google Scholar 

  5. Malabanan A Veronikis IE, Holick MF (1998) Redefining vitamin D insuficiency. Lancet 351: 805-806.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, The Saarland University Hospital, 66421, Homburg/Saar, Germany

    K. Querings & J. Reichrath

Authors
  1. K. Querings
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Reichrath
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Querings, K., Reichrath, J. A plea for the analysis of Vitamin-D levels in patients under photoprotection, including patients with xeroderma pigmentosum (XP) and basal cell nevus syndrome (BCNS). Cancer Causes Control 15, 219–220 (2004). https://doi.org/10.1023/B:CACO.0000019571.83095.97

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:CACO.0000019571.83095.97

Keywords

Search

Navigation